Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease DM Good, P Zürbig, A Argiles, HW Bauer, G Behrens, JJ Coon, M Dakna, ... Molecular & cellular proteomics 9 (11), 2424-2437, 2010 | 556 | 2010 |
Urinary proteomics in diabetes and CKD K Rossing, H Mischak, M Dakna, P Zürbig, J Novak, BA Julian, DM Good, ... Journal of the American Society of Nephrology 19 (7), 1283-1290, 2008 | 331 | 2008 |
Urinary proteomics for early diagnosis in diabetic nephropathy P Zürbig, G Jerums, P Hovind, RJ MacIsaac, H Mischak, SE Nielsen, ... Diabetes 61 (12), 3304-3313, 2012 | 297 | 2012 |
Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis S Decramer, S Wittke, H Mischak, P Zürbig, M Walden, F Bouissou, ... Nature medicine 12 (4), 398-400, 2006 | 288 | 2006 |
Urinary proteomic biomarkers in coronary artery disease LU Zimmerli, E Schiffer, P Zürbig, DM Good, M Kellmann, L Mouls, AR Pitt, ... Molecular & cellular proteomics 7 (2), 290-298, 2008 | 262 | 2008 |
Diagnosis and prediction of CKD progression by assessment of urinary peptides JP Schanstra, P Zürbig, A Alkhalaf, A Argiles, SJL Bakker, J Beige, ... Journal of the American Society of Nephrology 26 (8), 1999-2010, 2015 | 252 | 2015 |
CE‐MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics JJ Coon, P Zürbig, M Dakna, AF Dominiczak, S Decramer, D Fliser, ... Proteomics–Clinical Applications 2 (7‐8), 964-973, 2008 | 248 | 2008 |
Biomarker discovery by CE‐MS enables sequence analysis via MS/MS with platform‐independent separation P Zürbig, MB Renfrow, E Schiffer, J Novak, M Walden, S Wittke, I Just, ... Electrophoresis 27 (11), 2111-2125, 2006 | 221 | 2006 |
Proteins induced by telomere dysfunction and DNA damage represent biomarkers of human aging and disease H Jiang, E Schiffer, Z Song, J Wang, P Zürbig, K Thedieck, S Moes, ... Proceedings of the National Academy of Sciences 105 (32), 11299-11304, 2008 | 205 | 2008 |
Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational … N Tofte, M Lindhardt, K Adamova, SJL Bakker, J Beige, JWJ Beulens, ... The lancet Diabetes & endocrinology 8 (4), 301-312, 2020 | 204 | 2020 |
Discovery and validation of urinary biomarkers for prostate cancer D Theodorescu, E Schiffer, HW Bauer, F Douwes, F Eichhorn, R Polley, ... PROTEOMICS–Clinical Applications 2 (4), 556-570, 2008 | 178 | 2008 |
Human Proteinpedia enables sharing of human protein data S Mathivanan, M Ahmed, NG Ahn, H Alexandre, R Amanchy, PC Andrews, ... Nature biotechnology 26 (2), 164-167, 2008 | 178 | 2008 |
Proteomic patterns predict acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation EM Weissinger, E Schiffer, B Hertenstein, JL Ferrara, E Holler, M Stadler, ... Blood, The Journal of the American Society of Hematology 109 (12), 5511-5519, 2007 | 174 | 2007 |
Bile proteomic profiles differentiate cholangiocarcinoma from primary sclerosing cholangitis and choledocholithiasis TO Lankisch, J Metzger, AA Negm, K Voβkuhl, E Schiffer, J Siwy, ... Hepatology 53 (3), 875-884, 2011 | 172 | 2011 |
Urinary proteomics for prediction of preeclampsia DM Carty, J Siwy, JE Brennand, P Zürbig, W Mullen, J Franke, ... Hypertension 57 (3), 561-569, 2011 | 171 | 2011 |
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus SS Roscioni, D De Zeeuw, ME Hellemons, H Mischak, P Zürbig, ... Diabetologia 56, 259-267, 2013 | 165 | 2013 |
Comprehensive human urine standards for comparability and standardization in clinical proteome analysis H Mischak, W Kolch, M Aivaliotis, D Bouyssié, M Court, H Dihazi, ... Proteomics–Clinical Applications 4 (4), 464-478, 2010 | 157 | 2010 |
Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy A Alkhalaf, P Zürbig, SJL Bakker, HJG Bilo, M Cerna, C Fischer, S Fuchs, ... PloS one 5 (10), e13421, 2010 | 147 | 2010 |
Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers H Jahn, S Wittke, P Zürbig, TJ Raedler, S Arlt, M Kellmann, W Mullen, ... PloS one 6 (10), e26540, 2011 | 138 | 2011 |
Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy J Siwy, JP Schanstra, A Argiles, SJL Bakker, J Beige, P Boucek, K Brand, ... Nephrology Dialysis Transplantation 29 (8), 1563-1570, 2014 | 131 | 2014 |